Discontinued — last reported Q4 '25
Other Current Liabilities
Current LiabilitiesEli Lilly Other Current Liabilities increased by 62.2% to $8.46B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 67.4%, from $5.05B to $8.46B. Over 5 years (FY 2020 to FY 2025), Other Current Liabilities shows an upward trend with a 25.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ3 2017
Last reportedQ4 2025
How to read this metric
Generally stable; large spikes should be investigated for one-time legal settlements or unusual short-term obligations.
Detailed definition
A grouping of various short-term obligations that are not significant enough to be listed individually, such as dividend...
Peer comparison
Typically a small portion of the total liability structure for large-cap technology companies.
Metric ID:
other_current_liabilitiesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.62B | $2.33B | $3.03B | $2.54B | $2.00B | $1.99B | $2.37B | $2.19B | $2.27B | $2.59B | $3.28B | $4.20B | $4.25B | $5.58B | $5.05B | $3.77B | $5.08B | $5.22B | $8.46B |
| QoQ Change | — | -11.4% | +30.1% | -16.2% | -21.0% | -0.8% | +19.3% | -7.5% | +3.6% | +13.8% | +26.9% | +28.0% | +1.2% | +31.3% | -9.5% | -25.4% | +34.7% | +2.7% | +62.2% |
| YoY Change | — | — | — | — | -23.7% | -14.6% | -21.7% | -13.5% | +13.4% | +30.1% | +38.4% | +91.4% | +87.1% | +115.8% | +53.9% | -10.2% | +19.5% | -6.5% | +67.4% |
Range$1.99B – $8.46B
CAGR+29.7%
Avg YoY Growth+28.5%
Median YoY Growth+19.5%
Current Streak3 quarters growth
Other Current Liabilities at Other Companies
Frequently Asked Questions
- What is Eli Lilly's other current liabilities?
- Eli Lilly (LLY) reported other current liabilities of $8.46B in Q4 2025.
- How has Eli Lilly's other current liabilities changed year-over-year?
- Eli Lilly's other current liabilities increased by 67.4% year-over-year, from $5.05B to $8.46B.
- What is the long-term trend for Eli Lilly's other current liabilities?
- Over 5 years (2020 to 2025), Eli Lilly's other current liabilities has grown at a 25.2% compound annual growth rate (CAGR), from $2.75B to $8.46B.
- What does other current liabilities mean?
- Miscellaneous bills and short-term debts due within a year.